NasdaqGS:TXGLife Sciences
Is Ark Invest’s Steady Buying Reframing the Long-Term Product Expansion Story At 10x Genomics (TXG)?
Cathie Wood’s Ark Invest recently added to its position in 10x Genomics over four consecutive trading sessions, highlighting renewed institutional interest in the life sciences tools maker and its single-cell Chromium platform.
This persistent buying streak by a high-profile investor brings additional attention to 10x Genomics’ role in advanced genomics workflows, potentially influencing how other market participants view its long-term demand outlook.
We’ll now examine how Cathie Wood’s...